Abstract
We have previously shown that impulsivity in rats is linked to decreased dopamine D2/3 receptor availability in the ventral striatum. In the present study, we investigated, using longitudinal positron emission tomography (PET), the effects of orally administered methylphenidate (MPH), a first-line treatment for attention deficit hyperactivity disorder, on D2/3 receptor availability in the dorsal and ventral striatum and related these changes to impulsivity. Rats were screened for impulsive behavior on a five-choice serial reaction time task. After a baseline PET scan with the D2/3 ligand [(18)F]fallypride, rats received 6 mg/kg MPH, orally, twice each day for 28 d. Rats were then reassessed for impulsivity and underwent a second [(18)F]fallypride PET scan. Before MPH treatment, we found that D2/3 receptor availability was significantly decreased in the left but not the right ventral striatum of high-impulse (HI) rats compared with low-impulse (LI) rats. MPH treatment increased impulsivity in LI rats, and modulated impulsivity and D2/3 receptor availability in the dorsal and ventral striatum of HI rats through inverse relationships with baseline levels of impulsivity and D2/3 receptor availability, respectively. However, we foun...Continue Reading
Citations
Jul 3, 2015·The International Journal of Neuropsychopharmacology·Valerie VoonNeil A Harrison
Oct 27, 2015·Psychopharmacology·Ingrid ReverteMaria Teresa Colomina
Mar 24, 2016·Behavioural Processes·Sarah E SniderWarren K Bickel
Apr 20, 2016·Behavioural Brain Research·Alicia IzquierdoAlexandra Stolyarova
May 6, 2016·Psychopharmacology·Christopher P KingPaul J Meyer
Jul 28, 2016·Neuroscience and Biobehavioral Reviews·Aurelien BernheimCarmela M Reichel
Nov 20, 2016·Genes, Brain, and Behavior·L K DobbsV A Alvarez
Sep 30, 2016·Journal of Psychopharmacology·T W Robbins
Jan 28, 2018·Psychopharmacology·Rebecca L BarlowAnton Pekcec
Mar 20, 2018·The International Journal of Neuropsychopharmacology·Rebecca L BarlowAnton Pekcec
Sep 1, 2018·Behavioural Pharmacology·Madison R CarrTommy Pattij
Dec 21, 2018·PloS One·Fernando CaravaggioSimon Cervenka
Apr 6, 2019·Pharmacogenetics and Genomics·Tyler StevensTeri E Klein
Feb 28, 2018·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·T W Robbins
Jan 19, 2019·Psychopharmacology·M Caballero-PuntiverioJ T Andreasen
Nov 19, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Eva MartinezLéon Tremblay
Mar 21, 2017·Psychopharmacology·Yia-Ping LiuTrevor W Robbins
Jan 22, 2020·Scientific Reports·Eva MartinezLéon Tremblay
May 12, 2020·Frontiers in Pharmacology·Guy A HigginsJesper F Bastlund
Oct 21, 2015·Genes, Brain, and Behavior·D BelinJ W Dalley
Sep 22, 2018·Journal of Neural Transmission·Emily CariasPanayotis K Thanos
Apr 11, 2019·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Jeffrey W Dalley, Karen D Ersche
Feb 18, 2017·Nature Reviews. Neuroscience·Jeffrey W Dalley, Trevor W Robbins
Aug 10, 2019·Frontiers in Psychiatry·Manoranjan S D'Souza
Nov 6, 2020·The International Journal of Neuropsychopharmacology·Lidia BellésNathalie Ginovart
Jan 1, 2021·Frontiers in Psychiatry·Oliver GrimmAndreas Reif
Nov 26, 2019·Progress in Neuro-psychopharmacology & Biological Psychiatry·M Caballero-PuntiverioJ T Andreasen
Jul 21, 2020·Brain, Behavior, and Immunity·Wendy K AdamsCatharine A Winstanley
Jan 1, 2020·Neurobiology of Pain·Ana Margarida CunhaHugo Leite-Almeida